Skybiotech Healthcare
BSE: SKYBIOTECH INE393H01016
About Skybiotech Healthcare
Loading what this company does…
How the stock has moved
Skybiotech Healthcare (SKYBIOTECH) closed at ₹115.00 on 2 Nov 2026, down 0.86% on the day. The share price fell 36.2% over the past year (adjusted for splits and bonuses) and sits 47.7% below its highest close of the past year, ₹220.00.
Weak finances.
Worked out by Arthscan from the figures on this page, by fixed rules. A description of the data, not advice to buy or sell.
- Open
- 113.70
- Previous close
- 116.00
- Volume
- 1,653
- Value (₹ lakh)
- 1.90
- VWAP
- —
- Beta
- —
- Market cap (₹ Cr)
- 22
- High
- 117.15
- Low
- 113.70
- Upper circuit
- —
- Lower circuit
- —
- 52-week high
- 220.00
- 52-week low
- 113.90
- Face value
- —
- All-time high
- —
- All-time low
- —
- 20-day avg volume
- 94
- Book value per share
- 41.74
- Dividend yield
- 0.00%
- Debt to equity
- 0.92
- TTM EPS
- -6.70
- TTM P/E
- —
- P/B
- 2.76
- Sector P/E
- —
- ROE
- —
- ROCE
- -9.40%
Session of 2 Nov 2026. Prices and limits from Dhan for BSE; ratios from Dhan and company filings.
Chart
Candles from Dhan, BSE prices, times in IST. Past prices are adjusted for splits and bonuses. Your drawings and settings stay in this browser.
Forecast
Technicals
volume spike · 148.3x
Price & Volume
Returns
Volume
Seasonality
News
Against its industry
Textiles · from Dhan- Price to book cheaper than the industry
What you pay for each ₹1 of the company's net assets.
- Debt to equity more borrowed than the industry
Borrowed money for each ₹1 the owners have put in. Higher means more fixed interest to pay.
- Dividend yield pays less than the industry
Cash paid out each year as dividends, as a share of today's price.
The change is against the quarter before. A rise means these institutions bought more of the company's shares.
Financials
Source: Indian Stock API, from company filings. Annual columns are financial years; TTM is the trailing twelve months.